Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alborz Daru is a prominent Iranian pharmaceutical company headquartered in Tehran, with its primary manufacturing facilities located in the Alborz Industrial City of Qazvin. Founded in 1976, the company has established itself as a leader in the production of cardiovascular and central nervous system medications within the Iranian market. Its extensive product portfolio includes over 100 different pharmaceutical products across various therapeutic areas such as gastrointestinal, antibiotics, and analgesics. Alborz Daru operates under the umbrella of the Barakat Pharmaceutical Group and is publicly traded on the Tehran Stock Exchange. The company maintains high-quality manufacturing standards, utilizing GMP-certified facilities to produce solid, liquid, and injectable dosage forms for both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alborz Daru.